Researchers constructed FMR1 gene-truncated iPSCs by CRISPR/Cas9 and simulated some phenotypes of FXS in vitro by 2D neural culture and 3D brain organoids, respectively (Brighi et al., 2021). The gene discussed is FMR1; the disease is fragile X syndrome.